Modimelanotide is a melanocortinergic peptide drug derived from α-melanocyte-stimulating hormone (α-MSH) which was under development for the treatment of acute kidney injury. It acts as a non-selective melanocortin receptor agonist. References: Montero-Melendez T, Patel HB, Seed M, Nielsen S, Jonassen TE, Perretti M. The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties. Am J Pathol. 2011 Jul;179(1):259-69. doi: 10.1016/j.ajpath.2011.03.042. Epub 2011 May 10. PubMed PMID: 21703408; PubMed Central PMCID: PMC3123798.

纯度：≥98%

CAS：926277-68-1